Cargando…
Impact of Systemic Autoimmune Diseases on Treatment Outcomes and Radiation Toxicities in Patients with Stage I Non-Small Cell Lung Cancer Receiving Stereotactic Body Radiation Therapy: A Matched Case-Control Analysis
SIMPLE SUMMARY: Lung cancer is the leading cause of cancer-related deaths worldwide. Stereotactic body radiation therapy (SBRT) has become the standard treatment for inoperable early stage non-small-cell lung cancer (NSCLC). This study explored the relationship between systemic autoimmune diseases (...
Autores principales: | Chen, Zhe, Nonaka, Hotaka, Onishi, Hiroshi, Nakatani, Eiji, Oguri, Mitsuhiko, Saito, Masahide, Aoki, Shinichi, Marino, Kan, Komiyama, Takafumi, Kuriyama, Kengo, Araya, Masayuki, Tominaga, Licht, Saito, Ryo, Maehata, Yoshiyasu, Shinohara, Ryoji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740448/ https://www.ncbi.nlm.nih.gov/pubmed/36497397 http://dx.doi.org/10.3390/cancers14235915 |
Ejemplares similares
-
Modified Glasgow Prognostic Score is predictive of prognosis for non-small cell lung cancer patients treated with stereotactic body radiation therapy: a retrospective study
por: Chen, Zhe, et al.
Publicado: (2021) -
Renal Cancer is Not Radioresistant: Slowly but Continuing Shrinkage of the Tumor After Stereotactic Body Radiation Therapy
por: Funayama, Satoshi, et al.
Publicado: (2019) -
Immune Responses following Stereotactic Body Radiotherapy for Stage I Primary Lung Cancer
por: Maehata, Yoshiyasu, et al.
Publicado: (2013) -
Stereotactic body radiotherapy in patients with lung tumors composed of mainly ground-glass opacity
por: Onishi, Hiroshi, et al.
Publicado: (2020) -
Stereotactic Body Radiotherapy for Metachronous Multisite Oligo-Recurrence: A Long-Surviving Case with Sequential Oligo-Recurrence in Four Different Organs Treated Using Locally Radical Radiotherapy and a Review of the Literature
por: Onishi, Hiroshi, et al.
Publicado: (2012)